Antiischemic Properties of Fasudil in Experimental Models of Vasospastic Angina
Open Access
- 31 December 2001
- journal article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 87 (1) , 34-40
- https://doi.org/10.1254/jjp.87.34
Abstract
We studied the antiischemic properties of fasudil, a Rho-kinase inhibitor, in conscious rabbits with coronary vasospasm induced by vasopressin and endothelin. Pretreatment with fasudil (0.3 and 3 mg/kg) attenuated the maximum elevation of the T-wave elicited by endothelin. Pretreatment with fasudil inhibited the T-wave elevation elicited by vasopressin. Fasudil and hydroxy fasudil, an active metabolite of fasudil, relaxed the endothelin-, U-46619-, 5-hydroxytryptamine- or histamine-induced contraction in swine coronary arterial strips. Fasudil and hydroxy fasudil significantly prevented the reduction in coronary flow by vasopressin in the Langendorff perfused rat heart. Fasudil was effective in protecting the heart against vasopressin and endothelin-induced myocardial ischemic change in conscious rabbits, and this beneficial effect can be attributed to its action of ameliorating the severe contraction of arteries. The inhibition of Rho-kinase may have implications for the development of novel therapeutic strategies for vasospastic angina in patients.Keywords
This publication has 19 references indexed in Scilit:
- The Protein Kinase Inhibitor Fasudil Protects Against Ischemic Myocardial Injury Induced by Endothelin-1 in the RabbitJournal of Cardiovascular Pharmacology, 2000
- Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 2000
- Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasmCardiovascular Research, 1999
- Inhibition of Neutrophil Migration by a Protein Kinase Inhibitor for the Treatment of Ischemic Brain InfarctionThe Japanese Journal of Pharmacology, 1999
- Enhanced Myosin Light Chain Phosphorylations as a Central Mechanism for Coronary Artery Spasm in a Swine Model With Interleukin-1βCirculation, 1997
- Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077European Journal of Pharmacology, 1995
- Effects of SR 49059, a non‐peptide antagonist of vasopressin V1areceptors, on vasopressin‐induced coronary vasoconstriction in conscious rabbitsFundamental & Clinical Pharmacology, 1995
- Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhageJournal of Neurosurgery, 1992
- Cardioprotective effects of KRN2391 and nicorandil on ischemic dysfunction in perfused rat heartEuropean Journal of Pharmacology, 1991
- Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinaseBritish Journal of Pharmacology, 1989